268 related articles for article (PubMed ID: 25614109)
1. Saccharin: a lead compound for structure-based drug design of carbonic anhydrase IX inhibitors.
Mahon BP; Hendon AM; Driscoll JM; Rankin GM; Poulsen SA; Supuran CT; McKenna R
Bioorg Med Chem; 2015 Feb; 23(4):849-54. PubMed ID: 25614109
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into carbonic anhydrase IX isoform specificity of carbohydrate-based sulfamates.
Moeker J; Mahon BP; Bornaghi LF; Vullo D; Supuran CT; McKenna R; Poulsen SA
J Med Chem; 2014 Oct; 57(20):8635-45. PubMed ID: 25254302
[TBL] [Abstract][Full Text] [Related]
3. A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms.
Carradori S; Secci D; De Monte C; Mollica A; Ceruso M; Akdemir A; Sobolev AP; Codispoti R; De Cosmi F; Guglielmi P; Supuran CT
Bioorg Med Chem; 2016 Mar; 24(5):1095-105. PubMed ID: 26810710
[TBL] [Abstract][Full Text] [Related]
4. 1,3-Dipolar Cycloaddition, HPLC Enantioseparation, and Docking Studies of Saccharin/Isoxazole and Saccharin/Isoxazoline Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors.
D'Ascenzio M; Secci D; Carradori S; Zara S; Guglielmi P; Cirilli R; Pierini M; Poli G; Tuccinardi T; Angeli A; Supuran CT
J Med Chem; 2020 Mar; 63(5):2470-2488. PubMed ID: 31972093
[TBL] [Abstract][Full Text] [Related]
5. A sucrose-binding site provides a lead towards an isoform-specific inhibitor of the cancer-associated enzyme carbonic anhydrase IX.
Pinard MA; Aggarwal M; Mahon BP; Tu C; McKenna R
Acta Crystallogr F Struct Biol Commun; 2015 Oct; 71(Pt 10):1352-8. PubMed ID: 26457530
[TBL] [Abstract][Full Text] [Related]
6. N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII.
Ivanova J; Carta F; Vullo D; Leitans J; Kazaks A; Tars K; Žalubovskis R; Supuran CT
Bioorg Med Chem; 2017 Jul; 25(13):3583-3589. PubMed ID: 28416101
[TBL] [Abstract][Full Text] [Related]
7. Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties.
Genis C; Sippel KH; Case N; Cao W; Avvaru BS; Tartaglia LJ; Govindasamy L; Tu C; Agbandje-McKenna M; Silverman DN; Rosser CJ; McKenna R
Biochemistry; 2009 Feb; 48(6):1322-31. PubMed ID: 19170619
[TBL] [Abstract][Full Text] [Related]
8. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
[TBL] [Abstract][Full Text] [Related]
9. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.
Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA
Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000
[TBL] [Abstract][Full Text] [Related]
10. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
[TBL] [Abstract][Full Text] [Related]
11. Structural Basis of Saccharin Derivative Inhibition of Carbonic Anhydrase IX.
Leitans J; Kazaks A; Bogans J; Supuran CT; Akopjana I; Ivanova J; Zalubovskis R; Tars K
ChemMedChem; 2023 Nov; 18(22):e202300454. PubMed ID: 37837260
[TBL] [Abstract][Full Text] [Related]
12. N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.
Rodríguez OM; Maresca A; Témpera CA; Bravo RD; Colinas PA; Supuran CT
Bioorg Med Chem Lett; 2011 Aug; 21(15):4447-50. PubMed ID: 21723123
[TBL] [Abstract][Full Text] [Related]
13. Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
Guler OO; De Simone G; Supuran CT
Curr Med Chem; 2010; 17(15):1516-26. PubMed ID: 20166929
[TBL] [Abstract][Full Text] [Related]
14. Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship.
Gao R; Liao S; Zhang C; Zhu W; Wang L; Huang J; Zhao Z; Li H; Qian X; Xu Y
Eur J Med Chem; 2013 Apr; 62():597-604. PubMed ID: 23429054
[TBL] [Abstract][Full Text] [Related]
15. Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes.
Moeker J; Peat TS; Bornaghi LF; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2014 Apr; 57(8):3522-31. PubMed ID: 24689792
[TBL] [Abstract][Full Text] [Related]
16. Effect of incorporating a thiophene tail in the scaffold of acetazolamide on the inhibition of human carbonic anhydrase isoforms I, II, IX and XII.
Biswas S; McKenna R; Supuran CT
Bioorg Med Chem Lett; 2013 Oct; 23(20):5646-9. PubMed ID: 23993330
[TBL] [Abstract][Full Text] [Related]
17. Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.
Maresca A; Supuran CT
Bioorg Med Chem Lett; 2010 Aug; 20(15):4511-4. PubMed ID: 20580555
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
Sarikaya B; Ceruso M; Carta F; Supuran CT
Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII.
Güzel-Akdemir Ö; Akdemir A; Karalı N; Supuran CT
Org Biomol Chem; 2015 Jun; 13(23):6493-9. PubMed ID: 25967275
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII.
D'Ascenzio M; Carradori S; De Monte C; Secci D; Ceruso M; Supuran CT
Bioorg Med Chem; 2014 Mar; 22(6):1821-31. PubMed ID: 24560739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
